ABSTRACT
Capnocytophaga canimorsus (CP) causes severe infections in immunocompromised individuals. Three serovars (A, B, and C) are known to be responsible for more than 90% of infections associated with dog bites, although these three constitute only 8% of the serovars carried by dogs. We experienced a post-splenectomy non-severe case of CP withserovar type E, which has never been isolated in Japan. The prognosis of type E CP infections may be better than that of types A, B, and C infections because of the disproportion of serovars between clinical human isolates and dog oral isolates.
ABSTRACT
Background: Introduction of the Haemophilus influenzae serotype b (Hib) conjugate vaccine has changed the epidemiology of invasive H. influenzae disease, with most infections now caused by non-typeable (non-encapsulated) and non-Hib encapsulated strains. Methods: We describe nine invasive serotype e H. influenzae (Hie) from British Columbia that were determined to have complete deletion of their fucose operon genes. These nine isolates were recovered from blood cultures of three female and six male patients during 2011-2018, with eight recovered in the past 4 years. Results: All nine isolates were biotype IV, with eight showing identical pulsed field gel electrophoresis (PFGE) profiles, whereas the ninth showed 95% similarity. PFGE analysis also showed these fucose operon-negative Hie to be most (94%) similar to the multi-locus sequence type (ST)-18, the most common ST among Hie in British Columbia. These nine fucose operon-negative Hie represented 27.3% of the 33 invasive Hie isolated in British Columbia from 2010 to 2018. Conclusion: Deletion of the fucose operon did not appear to impact the transmission ability of these strains or their ability to cause invasive disease.
Historique: L'adoption du vaccin conjugué contre l'Haemophilus influenzae de sérotype b (Hib) a modifié l'épidémiologie de la maladie à H. influenzae invasive, car la plupart des infections sont désormais causées par des souches non typables (non encapsulées) plutôt que par des souches encapsulées non Hib. Méthodologie: Les auteurs décrivent neuf cas d'H. influenzae de sérotype e (Hie) invasif de la Colombie-Britannique, dont la délétion des gènes de l'opéron fucose était considérée comme complète. Ces neuf isolats ont été prélevés dans les hémocultures de trois patientes et de six patients entre 2011 et 2018, dont huit récupérés dans les quatre années précédentes. Résultats: Les neuf isolats étaient de biotype IV, et huit possédaient un profil d'électrophorèse sur gel à champ pulsé (PFGE) identique, alors que le neuvième était similaire à 95 %. L'analyse PFGE a également révélé que les Hie négatifs à cet opéron fucose sont les plus (94 %) semblables au typage génomique multilocus (ST)-18, qui sont les ST les plus fréquents dans les souches de Hie en Colombie-Britannique. Ces neuf Hie négatifs à l'opéron fucose représentaient 27,3 % des 33 Hie invasifs isolés en Colombie-Britannique entre 2010 et 2018. Conclusion: La délétion de l'opéron fucose ne semblait pas avoir d'effet sur la capacité de transmission de ces souches ni sur la capacité de provoquer d'autres maladies invasives.
ABSTRACT
Naturally occurring botulinum toxin (BoNT) serotypes have different pharmacological features of therapeutic and aesthetic interest. This phase 1, double-blind, placebo-controlled study (EudraCT: 2016-002609-20) assessed safety, tolerability and pharmacodynamics (PD) of the first recombinant BoNT serotype E (rBoNT-E) versus abobotulinumtoxinA (Dysport®), administered to extensor digitorum brevis (EDB) of healthy males. Subjects were randomised 3:1 (nâ¯=â¯28) to single ascending rBoNT-E (0.04-3.6â¯ng) doses or placebo. A further 24 subjects received abobotulinumtoxinA (20, 40, or 70â¯U) or placebo. PD were assessed using compound muscle action potential (CMAP) amplitude. Demographics were similar between groups. All rBoNT-E doses were well tolerated (no severe treatment-emergent adverse events [TEAEs], serious adverse events, or treatment-related toxicities). Most TEAEs were mild/moderate and treatment-unrelated. rBoNT-E had a faster onset of action (days 1-2 post-injection), greater peak effect (>90% CMAP inhibition), and shorter duration of effect at highest tested doses versus abobotulinumtoxinA (onset of action ≤7â¯days post-injection; 70% maximal CMAP inhibition). rBoNT-E duration of effect was 2-7â¯weeks versus >26â¯weeks for abobotulinumtoxinA. Dose-dependent effects were observed for magnitude and duration of EDB CMAP inhibition, plateauing at 0.9 and 3.6â¯ng. rBoNT-E demonstrated a good safety profile and a PD profile that may address unmet therapeutic and aesthetic patient needs.
Subject(s)
Acetylcholine Release Inhibitors/adverse effects , Botulinum Toxins, Type A/adverse effects , Botulinum Toxins/adverse effects , Acetylcholine Release Inhibitors/pharmacology , Adolescent , Adult , Botulinum Toxins/pharmacology , Botulinum Toxins, Type A/pharmacology , Double-Blind Method , Humans , Male , Middle Aged , Treatment Outcome , Young AdultABSTRACT
Introduction. Certain nontypeable Haemophilus influenzae cannot be assigned a sequence type (ST) by Multilocus Sequence Typing (MLST) due to the lack of the fucK gene, one of seven MLST loci in H. influenzae, which encodes a fucose-operon enzyme.Aims. To confirm whether the loss of fucK is also found in the encapsulated strains, we analysed clinical isolates of H. influenzae serotype e (Hie).Methodology. We conducted MLST, PFGE, and antimicrobial susceptibility tests of 45 Hie strains; the majority (n=43) were derived from respiratory samples of pediatric patients at Chiba Children's Hospital between 2000 and 2016. The two remaining strains were obtained from the blood of elderly patients with invasive H. influenzae diseases (IHiDs) between 2015 and 2016 at general hospitals. For the fucK-negative strains, PCR analysis for fucose operon was also performed.Results. Four STs (ST18, 122, 621 and 1758) were assigned to 13 strains, and remaining 32 (including one associated with IHiD) were fucK-negative, completely missing the fucose operon. The allelic profiles of six other loci were identical among 31 strains and to that of ST18, 122 and 621, and these strains were genetically closely related. Forty of 45 isolates were ampicillin-sensitive.Conclusions. The loss of fucK was frequently observed in clinical isolates of Hie from children. Moreover, fucK-negative Hie may be the cause of IHiD in adult patients. The majority of Hie, including fucK-negative strains, were shown to be clonally related and were ampicillin sensitive. This represents the first report examining fucK losses in encapsulated H. influenzae.
Subject(s)
Bacterial Proteins/genetics , Haemophilus Infections/microbiology , Haemophilus influenzae/isolation & purification , Phosphotransferases (Alcohol Group Acceptor)/genetics , Adolescent , Ampicillin/pharmacology , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/metabolism , Child , Child, Preschool , Female , Haemophilus influenzae/classification , Haemophilus influenzae/drug effects , Haemophilus influenzae/genetics , Humans , Japan , Male , Multilocus Sequence Typing , Operon , Phosphotransferases (Alcohol Group Acceptor)/deficiency , PhylogenyABSTRACT
Botulism is a devastating disease caused by botulinum neurotoxins (BoNTs) secreted primarily by Clostridium botulinum. Mouse bioassays without co-inoculation with antibodies are the standard method for the detection of BoNTs, but are not capable of distinguishing between the different serotypes (A-G). Most foodborne intoxications are caused by serotypes BoNT/A and BoNT/B. BoNT/E outbreaks are most often observed in northern coastal regions and are associated with eating contaminated marine animals and other fishery products. Sandwich enzyme-linked immunosorbent assays (ELISAs) were developed for the detection of BoNT/E3. Monoclonal antibodies (mAbs) were generated against BoNT/E3 by immunizing with recombinant peptide fragments of the light and heavy chains of BoNT/E3. In all, 12 mAbs where characterized for binding to both the recombinant peptides and holotoxin, as well as their performance in Western blots and sandwich ELISAs. The most sensitive sandwich assay, using different mAbs for capture and detection, exhibited a limit of detection of 0.2 ng/ml in standard buffer matrix and 10 ng/mL in fish product matrices. By employing two different mAbs for capture and detection, a more standardized sandwich assay was constructed. Development of sensitive and selective mAbs to BoNT/E would help in the initial screening of potential food contamination, speeding diagnosis and reducing use of laboratory animals.
Subject(s)
Antibodies, Monoclonal/analysis , Botulinum Toxins/immunology , Neurotoxins/immunology , Peptide Fragments/immunology , Recombinant Fusion Proteins/immunology , Animals , Antibodies, Monoclonal/immunology , Botulism/prevention & control , Eggs/analysis , Enzyme-Linked Immunosorbent Assay , Epitopes/immunology , Female , Food Contamination/analysis , Food, Preserved/analysis , Glutathione Transferase/genetics , Glutathione Transferase/immunology , Mice, Inbred BALB C , Perciformes , SalmonABSTRACT
Human botulism is most commonly caused by botulinum neurotoxin (BoNT) serotypes A, B, and E. For this work, we sought to develop a human monoclonal antibody (mAb)-based antitoxin capable of binding and neutralizing multiple subtypes of BoNT/E. Libraries of yeast-displayed single chain Fv (scFv) antibodies were created from the heavy and light chain variable region genes of humans immunized with pentavalent-toxoid- and BoNT/E-binding scFv isolated by Fluorescence-Activated Cell Sorting (FACS). A total of 10 scFv were isolated that bound one or more BoNT/E subtypes with nanomolar-level equilibrium dissociation constants (KD). By diversifying the V-regions of the lead mAbs and selecting for cross-reactivity, we generated three scFv that bound all four BoNT/E subtypes tested at three non-overlapping epitopes. The scFvs were converted to IgG that had KD values for the different BoNT/E subtypes ranging from 9.7 nM to 2.28 pM. An equimolar combination of the three mAbs was able to potently neutralize BoNT/E1, BoNT/E3, and BoNT/E4 in a mouse neutralization assay. The mAbs have potential utility as therapeutics and as diagnostics capable of recognizing multiple BoNT/E subtypes. A derivative of the three-antibody combination (NTM-1633) is in pre-clinical development with an investigational new drug (IND) application filing expected in 2018.
Subject(s)
Antibodies, Monoclonal/immunology , Antibodies, Neutralizing/immunology , Botulinum Toxins/immunology , Drug Combinations , Epitopes , HumansABSTRACT
Visceral toxicosis of catfish (VTC), a sporadic disease of cultured channel catfish (Ictalurus punctatus) often with high mortality, is caused by botulinum neurotoxin serotype E (BoNT/E). Presumptive diagnosis of VTC is based on characteristic clinical signs and lesions, and the production of these signs and mortality after sera from affected fish is administered to sentinel catfish. The diagnosis is confirmed if the toxicity is neutralized with BoNT/E antitoxin. Because small catfish are often unavailable, the utility of adult zebrafish (Danio rerio) was evaluated in BoNT/E and VTC bioassays. Channel catfish and zebrafish susceptibilities were compared using trypsin-activated BoNT/E in a 96-hr trial by intracoelomically administering 0, 1.87, 3.7, 7.5, 15, or 30 pg of toxin per gram of body weight (g-bw) of fish. All of the zebrafish died at the 7.5 pg/g-bw and higher, while the catfish died at the 15 pg/g-bw dose and higher. To test the bioassay, sera from VTC-affected fish or control sera were intracoelomically injected at a dose of 10 µl per zebrafish and 20 µl/g-bw for channel catfish. At 96 hr post-injection, 78% of the zebrafish and 50% of the catfish receiving VTC sera died, while no control fish died. When the VTC sera were preincubated with BoNT/E antitoxin, they became nontoxic to zebrafish. Histology of zebrafish injected with either VTC serum or BoNT/E demonstrated renal necrosis. Normal catfish serum was toxic to larval zebrafish in immersion exposures, abrogating their utility in VTC bioassays. The results demonstrate bioassays using adult zebrafish for detecting BoNT/E and VTC are sensitive and practical.